Latest Vascepa Lawsuit Plunges Hikma Into Induced Infringement Battle

Amarin Files Over Icosapent Ethyl Capsules And Cardiovascular Indication Patents

Amarin website logo
Amarin is claiming that Hikma’s Vascepa generic induces infringement of cardiovascular use patents • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin